The Development of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Caroline Goodner Introduction. Chronic Myeloid Leukemia is a cancer of the myeloid progenitor cells in the bone marrow that results after a random translocation between chromosomes 9 and 22 forms an oncogenic BCR-ABL gene. This disease began to be successfully treated after the discovery of the drug Imatinib, a tyrosine…